3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Doxorubicin
6
pazopanib
5
Trabectedin
4
Radiotherapy
3
temsirolimus
2
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Ifosfamide
2
Dexamethasone
2
sitravatinib
1
selinexor
1
saracatinib
1
romidepsin
1
regorafenib
1
plitidepsin
1
pembrolizumab
1
palbociclib
1
olaratumab
1
milademetan
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
efatutazone
1
cixutumumab
1
brigimadlin
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liposarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
No trials found.